CBI Scene Blog

5 Tips to Manage Transparency & Aggregate Spend Dispute Resolution

Posted by Logan Fleck on Jul 8, 2014 1:18:00 PM

The medical sciences field comes with a wide range of uphill battles. There are about a million different issues and one major issue is open payment disputes. It is always helpful to identify those individuals in a company that are going to be able to help deal with open payments disputes. These individuals should be skilled in dealing with issues quickly and easily to help make the process run smoothly.

Read More

Topics: Aggregate Spend, Compliance & Regulatory

How to Establish Effective Global Transparency Reporting

Posted by Joseph D on Jun 27, 2014 11:36:00 AM

When it comes to exchanges of value with health care professionals and organizations, life science companies are faced with a myriad of transparency laws and industry codes. This complicated regulatory environment is predicted to become more extensive in 2014 and beyond, making it important for these companies to understand their reporting requirements and optimize their systems. Many life science companies are taking a global approach to compliance, which is prompting them to improve the efficiency of their data management systems.

Read More

Topics: Aggregate Spend, Global Transparency, Compliance & Regulatory, sunshine act

Requirements for Open Payments Reporting for Clinical Research

Posted by Miranda B on Jun 19, 2014 10:00:00 AM

According to the Centers for Medicare and Medicaid Services, there has been a final ruling on the National Physician Payment Transparency Program: Open Payments, better known as the Sunshine Act. Under the Open Payments program, data collection of medical device and drug manufacturers who send gifts and payments to physicians and teaching hospitals is now mandatory. This applies to any manufacturer who receives government reimbursement, and collection data will be posted on a public website as of September 30, 2014.

Read More

Topics: Aggregate Spend, Compliance & Regulatory, sunshine act, Clinical

How to Prepare for Public Disclosure of Sunshine Data

Posted by Logan Fleck on Jun 9, 2014 10:14:00 AM



The March 31, 2014 deadline for submitting reports reflecting the financial relationships between biotech companies, group-purchasing organizations (GPOs), pharmaceutical companies and medical device manufacturers passed. Physicians now have 45-days to review the reports for errors before the Centers for the Medicare and Medicaid Services (CMS) database goes online.

Read More

Topics: Aggregate Spend, Compliance & Regulatory

Top Ten Takeaways from CBI's Global Transparency Reporting Congress

Posted by Katie Silverstein on May 15, 2013 11:17:00 AM

Read More

Topics: Aggregate Spend, Global Transparency, sunshine act

CBI's Aggregate Spend Series -- How It All Began and Where It's Going

Posted by Lauren Donoghue on May 13, 2013 10:03:00 AM

Read More

Topics: Aggregate Spend, Compliance & Regulatory, sunshine act